Cargando…
Hepatitis C Virus Epidemiology in Lithuania: Situation before Introduction of the National Screening Programme
In 2022, the Lithuanian health authorities decided to pay general practitioners a fee for performing serological tests for hepatitis C virus (HCV) antibodies in the population born from 1945 to 1994 once per life and annual HCV testing for PWID and HIV infected patients. This study aimed to assess t...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9230764/ https://www.ncbi.nlm.nih.gov/pubmed/35746663 http://dx.doi.org/10.3390/v14061192 |
_version_ | 1784735148236865536 |
---|---|
author | Ciupkeviciene, Egle Petkeviciene, Janina Sumskiene, Jolanta Dragunas, Gediminas Dabravalskis, Saulius Kreivenaite, Edita Telksnys, Tadas Urbonas, Gediminas Kupcinskas, Limas |
author_facet | Ciupkeviciene, Egle Petkeviciene, Janina Sumskiene, Jolanta Dragunas, Gediminas Dabravalskis, Saulius Kreivenaite, Edita Telksnys, Tadas Urbonas, Gediminas Kupcinskas, Limas |
author_sort | Ciupkeviciene, Egle |
collection | PubMed |
description | In 2022, the Lithuanian health authorities decided to pay general practitioners a fee for performing serological tests for hepatitis C virus (HCV) antibodies in the population born from 1945 to 1994 once per life and annual HCV testing for PWID and HIV infected patients. This study aimed to assess trends in HCV-related mortality in the country and the prevalence of HCV infection among patients with liver diseases and evaluate possibilities of screening for HCV infection at a primary health care center. Age-standardized mortality rates in 2010–2020 were calculated for deaths caused by chronic hepatitis C and some liver diseases. Data on HCV infection among patients with liver cirrhosis, cancer and transplant patients were collected from the tertiary care hospital Kauno Klinikos. The prevalence of anti-HCV and risk factors of HCV infection was assessed among patients registered with the health care center in Klaipeda, where a pilot study of screening was performed. No steady trend in mortality was observed. Analysis of medical documentation showed that 40.5% of patients with liver cirrhosis, 49.7% with cancers and 36.9% of transplant patients were HCV infected. Over the year, 4867 patients were screened in the primary health care center. Positive anti-HCV prevalence was 1.7% (2.1% in men and 1.3% in women). Blood transfusion and being a blood donor before 1993 also having tattoos were associated with higher odds of HCV infection. The study revealed the active participation of individuals in HCV screening. |
format | Online Article Text |
id | pubmed-9230764 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-92307642022-06-25 Hepatitis C Virus Epidemiology in Lithuania: Situation before Introduction of the National Screening Programme Ciupkeviciene, Egle Petkeviciene, Janina Sumskiene, Jolanta Dragunas, Gediminas Dabravalskis, Saulius Kreivenaite, Edita Telksnys, Tadas Urbonas, Gediminas Kupcinskas, Limas Viruses Article In 2022, the Lithuanian health authorities decided to pay general practitioners a fee for performing serological tests for hepatitis C virus (HCV) antibodies in the population born from 1945 to 1994 once per life and annual HCV testing for PWID and HIV infected patients. This study aimed to assess trends in HCV-related mortality in the country and the prevalence of HCV infection among patients with liver diseases and evaluate possibilities of screening for HCV infection at a primary health care center. Age-standardized mortality rates in 2010–2020 were calculated for deaths caused by chronic hepatitis C and some liver diseases. Data on HCV infection among patients with liver cirrhosis, cancer and transplant patients were collected from the tertiary care hospital Kauno Klinikos. The prevalence of anti-HCV and risk factors of HCV infection was assessed among patients registered with the health care center in Klaipeda, where a pilot study of screening was performed. No steady trend in mortality was observed. Analysis of medical documentation showed that 40.5% of patients with liver cirrhosis, 49.7% with cancers and 36.9% of transplant patients were HCV infected. Over the year, 4867 patients were screened in the primary health care center. Positive anti-HCV prevalence was 1.7% (2.1% in men and 1.3% in women). Blood transfusion and being a blood donor before 1993 also having tattoos were associated with higher odds of HCV infection. The study revealed the active participation of individuals in HCV screening. MDPI 2022-05-30 /pmc/articles/PMC9230764/ /pubmed/35746663 http://dx.doi.org/10.3390/v14061192 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Ciupkeviciene, Egle Petkeviciene, Janina Sumskiene, Jolanta Dragunas, Gediminas Dabravalskis, Saulius Kreivenaite, Edita Telksnys, Tadas Urbonas, Gediminas Kupcinskas, Limas Hepatitis C Virus Epidemiology in Lithuania: Situation before Introduction of the National Screening Programme |
title | Hepatitis C Virus Epidemiology in Lithuania: Situation before Introduction of the National Screening Programme |
title_full | Hepatitis C Virus Epidemiology in Lithuania: Situation before Introduction of the National Screening Programme |
title_fullStr | Hepatitis C Virus Epidemiology in Lithuania: Situation before Introduction of the National Screening Programme |
title_full_unstemmed | Hepatitis C Virus Epidemiology in Lithuania: Situation before Introduction of the National Screening Programme |
title_short | Hepatitis C Virus Epidemiology in Lithuania: Situation before Introduction of the National Screening Programme |
title_sort | hepatitis c virus epidemiology in lithuania: situation before introduction of the national screening programme |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9230764/ https://www.ncbi.nlm.nih.gov/pubmed/35746663 http://dx.doi.org/10.3390/v14061192 |
work_keys_str_mv | AT ciupkevicieneegle hepatitiscvirusepidemiologyinlithuaniasituationbeforeintroductionofthenationalscreeningprogramme AT petkevicienejanina hepatitiscvirusepidemiologyinlithuaniasituationbeforeintroductionofthenationalscreeningprogramme AT sumskienejolanta hepatitiscvirusepidemiologyinlithuaniasituationbeforeintroductionofthenationalscreeningprogramme AT dragunasgediminas hepatitiscvirusepidemiologyinlithuaniasituationbeforeintroductionofthenationalscreeningprogramme AT dabravalskissaulius hepatitiscvirusepidemiologyinlithuaniasituationbeforeintroductionofthenationalscreeningprogramme AT kreivenaiteedita hepatitiscvirusepidemiologyinlithuaniasituationbeforeintroductionofthenationalscreeningprogramme AT telksnystadas hepatitiscvirusepidemiologyinlithuaniasituationbeforeintroductionofthenationalscreeningprogramme AT urbonasgediminas hepatitiscvirusepidemiologyinlithuaniasituationbeforeintroductionofthenationalscreeningprogramme AT kupcinskaslimas hepatitiscvirusepidemiologyinlithuaniasituationbeforeintroductionofthenationalscreeningprogramme |